Industry Trends

Loading...

Clinical Research
Off-shoring: A Country Attractiveness Index for Clinical Trials

By Mark P. Mathieu
For many years, pharmaceutical companies have been off-shoring manufacturing operations to lower-cost countries. Healthy margins and strong risk aversion have afforded pharmaceutical companies the luxury of staying close to home, for all but manufacturing activities. As financial pressures increase, pharmaceutical executives are finding that going offshore is not only less risky than it once was, but also too attractive to ignore.  Read More



Site Solutions for All that Ails EDC



Loading...

By Deb Borfitz

June 22, 2009 | In a recent issue of eCliniqua, investigative sites aired their frustrations with many of the e-clinical technologies embraced by study sponsors. They made particular note of technical deficiencies with electronic data capture (EDC) systems. But, as discussed below, they also offered some solid remedies for improving the situation.

Sponsors building electronic case report forms (eCRFs) in-house might want to start pre-populating data fields with information from subjects’ prior visits, says Diane Palmer, site administrator and clinical research coordinator at New London, Conn.-based Coastal Connecticut Research (CCR). Better yet, site personnel could enter study visit data on a single page.

The Holy Grail of eCRFs would be for the industry as a whole to come up with standards for data entry, she continues. For sites like CCR doing multiple studies, it’s difficult to remember company-specific requirements for inputting information. There are four alternatives for the date format alone: 5/26/2009, 26May2009, 26May09, or 5/26/09. Failure to follow data-entry rules results in automatically generated, time-consuming queries, which steals time from patient recruitment activities.

Palmer declares Phase Forward’s Inform EDC system “one of the best” and worthy of mimicking, including its online training module that includes a printed certificate of completion. Unfortunately, she adds, companies rarely accept the certificate as proof of training for subsequent studies using the same system. She can complete the online test in ten minutes because she knows the answers by heart. Ironically, being a speedy test-taker flags her as a potential cheater in the eyes of some sponsors.

EDC systems as a rule fail to provide the kind of information that could make life easier for sites, such as a study’s enrollment status, according to Richard Litov, director of Pedia Research in Owensboro, KY. Instead, they deliver the intelligence six weeks late via hardcopy newsletters. “Sponsors and CROs can see that information [electronically]. Why not us too?”

Similarly, adds Litov, central lab vendors continue to transmit lab values via fax. In an ideal world, sites would receive lab reports electronically, including a graphic display comparing current and previous lab values of a study subject so investigators don’t have to sift through paper charts to detect important changes. Doing so “would lead to better oversight and evaluation of safety.”

Litov says it would serve sponsors’ interests to involve at least a few sites in the technology acquisition process and then conduct post-study surveys to learn how well a chosen EDC system performs in the real world. “We’ve seen a sponsor switch to a different EDC system for each of three studies conducted in the same program.”

From the standpoint of consistency and accuracy, it would be advantageous for sponsors to provide a standard, study-specific template for source document forms rather than rely on each site to generate their own forms from scratch, especially since these forms mirror the CRFs that are already produced, says Litov. He estimates that Pedia Research donates between 5-20 hours of “secretarial work” per study to create the requisite forms. “Multiply that by 50 or more sites for a multi-center trial and that is a lot of wasted time diverting sites from starting up a study.”

Kelly Walker, chief operating officer at Research Across America (RAA) in Dallas, believes it is time EDC systems were incorporating user-friendly handwriting or voice recognition features. Knowing it could be a long wait, he has taken matters into his own hands by developing a single-data-entry system called DB Pharma, with a programmer familiar with Microsoft tools.

DB Pharma, run off a wireless tablet, utilizes handwriting recognition technology and immediately transmits data to a web host. But it only gets used on a few studies a year, when RAA is responsible for either all of the data capture or all of the data analysis. The system’s only downside, Walker says, is that it doesn’t accommodate doctors’ notoriously sloppy script.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

oracle20723
The Role of Analytics in Transforming Healthcare
Sponsored by Oracle

Sharing many of the data challenges and opportunities faced by Healthcare, the Life Sciences industry remains focused on delivering new, innovative therapies and solutions to patients in a cost effective, timely and safe way. With spiraling R&D costs, new methods such as adaptive trials, and never ending need for deep pharmacovigilance, the Life Sciences companies that effectively use analytics to explore, monitor and optimize their business will rapidly become the new leaders.

Oracle’s strategy—built upon Enterprise Health Analytics and Health Data Warehouse Foundation—provides a powerful, practical, and extensible approach to delivering the IT analytics infrastructure required to confront the worldwide healthcare challenge.



pegasystems
BPM-Based Case Management Approach to Optimizing Clinical Trial Efficiency
Sponsored by Pegasystems

Business Process Management (BPM) software offers liberation in the planning and management of clinical trials today. SmartBPM provides the components for automating critical clinical trial processes ranging from protocol development and patient enrollment to site management and investigator payments. Advantages are:

  • Potentially stunning return on investment at multiple levels.
  • A 500%, or better, increase in application development time by directly executing business requirements
  • Improved customer retention
  • A 50% possible reduction in training time

Discovered is opportunity to enhance relationships with investigators, subjects, and regulators while bringing momentum to a technology-impaired study startup phase. Learn more about SmartBPM in this complimentary white paper.



Cmed paper
Next-gen Cloud-based eClinical
Sponsored by Cmed Technology

New technologies are available to leverage Cloud Computing in  managing clinical trial data. This paper discusses a next generation eClinical
platform that:

  • Speeds trial set up
  • Accommodates changes with zero downtime
  • Integrates effectively with other clinical trial technology systems

It is offered with either software-as-a-service (SaaS), or turnkey infrastructure options in which the user organization operates their own cloud using their IT teams, within their data centers. Read this paper to learn and decide how best to leverage cloud computing’s many strengths for your organization’s  particular needs.



Life Science Webcasts & Podcasts

Medidata Solutions

Evaluating a Risk-based Approach to Good Clinical Practice 

medidata5_podcastThe verification of source documents by study monitors at investigational sites is considered a good clinical practice by regulatory authorities overseeing clinical research, and is extremely important to ensuring data quality in clinical trials. Today’s challenging environment is prompting study teams to explore the use of risk-based approaches to monitoring that do not compromise data quality, but allow limited resources to be directed more effectively to where they’re most needed and to the most critical review activities.

In this podcast, industry experts and executives from Medidata will address questions such as:

  • Why are regulatory agencies and industry open to evaluating the new approaches in site monitoring and source document verification (SDV), and what attitudes and reactions towards less than 100% SDV?
  • What factors do research sponsors need to consider in adopting risk-based site monitoring?


Download Now 



More Podcasts

Job Openings

mskc logo
Software Engineer – Computational Biology Center

Memorial Sloan-Kettering Cancer Center seeks an Engineer to design and develop complex data analysis systems in support of cancer genomics research projects at the Computational Biology Center. Qualified candidate will have a BA, 5+ years of software development experience and expert knowledge of Java, SQL, and HTML.

Apply: www.mskcciscareers.org.  Equal opportunity and affirmative action employer.

Loading...

For reprints and/or copyright permission, please contact The YGS Group, 3650 West Market Street, York, PA;

(717) 505-9701 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.